Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average, modest growth trend.
Left:
||||
Price-to-book ratio
Latest
14.92
↑ 95% above average
Average (9y)
7.64
Historical baseline
Range
High:14.92
Low:3.55
CAGR
+7.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 14.92 | +16.8% |
| 2023 | 12.77 | +39.0% |
| 2022 | 9.19 | +48.7% |
| 2021 | 6.18 | -15.3% |
| 2020 | 7.30 | +97.4% |
| 2019 | 3.70 | +4.0% |
| 2018 | 3.55 | -30.8% |
| 2017 | 5.13 | -12.6% |
| 2016 | 5.87 | -24.4% |
| 2015 | 7.77 | - |